Summary:
- Roche announced the launch of its new artificial intelligence (AI) platform, Roche AI, which aims to accelerate drug discovery and development by leveraging advanced AI and machine learning technologies.
- The Roche AI platform will be used to analyze large datasets, identify new drug targets, and optimize the design of clinical trials, with the goal of improving the efficiency and success rate of Roche's drug development pipeline.
- The platform will be integrated with Roche's existing research and development capabilities, allowing the company to combine the power of AI with its deep expertise in the life sciences and healthcare industries.